Mascoma Wealth Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Mascoma Wealth Management's RGEN Position: Q3 2026 in Review
Mascoma Wealth Management sold out of Repligen (RGEN) in Q3 2026, closing a stake of 5 shares — an estimated $682 sold.
Mascoma Wealth Management first reported a position in RGEN in Q1 2019 and held it in 3 quarters. The position peaked at $60K in Q2 2019. 85 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- Mascoma Wealth Management reported no remaining Repligen position as of Q3 2026 after selling out during the quarter.
- Mascoma Wealth Management sold 5 Repligen shares in Q3 2026, an estimated $682.
- Mascoma Wealth Management first reported a position in Repligen in Q1 2019 and held it in 3 quarters.
- Mascoma Wealth Management's Repligen position peaked at $60K in Q2 2019.
- 85 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on Mascoma Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.